Been holding ACTC for years but I wonder why management can't provide any data. Phase I has been over for months and results were suppose to be issued in December. Can't understand why it takes months to provide the results. All they were trying to prove in Phase I is whether their process was safe enough to continue into Phase II. Shouldn't be that big of a deal. Also, has anyone ever seen any formal written data that suggest the ACTC stem cells has improved the sight of anyone they treated? I don't need smart response, just facts.
Hi Razor, It often takes several months from time of article data submission until actual publication. Time for very busy professional Ophthalmologists/Ph.D academics to review the data and recommend changes, collation of this professional feedback and return to ACTC scientists for revisions. Resubmission, and then getting into the actual publication queue. In short, I do not view this time period of waiting to be extraordinary. Also, a friend of mine, who is a practicing Ophthalmologist, says that reversal of this type of macular degeneration simply NEVER happens. He also says that if it continues to be safe, and the vision improvement is validated, patients would be lined up at his office door.
Thanks biocoach for your positive response. I was under the impression that Phase I was to be completed in December and that results would be out shortly after that. I guess I am just getting nervous watching it go up and down while we wait. Just hope that we get positive news soon.
Phase 1 has not been completed for months and based on the last information that was received has at least a few more patients to inject. I would also note that their has been no clear distinction as to whether cohort 4 has officially been removed or not.